Division of Gastroenterological, Hepato-Biliary-Pancreatic, Transplantation and Pediatric Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.
World J Gastroenterol. 2023 Feb 7;29(5):867-878. doi: 10.3748/wjg.v29.i5.867.
Although the associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) induces more rapid liver regeneration than portal vein embolization, the mechanism remains unclear.
To assess the influence of inflammatory cytokines and endothelial nitric oxide synthase (eNOS) activation on liver regeneration in ALPPS.
The future liver remnant/body weight (FLR/BW) ratio, hepatocyte proliferation, inflammatory cytokine expression, and activation of the Akt-eNOS pathway were evaluated in rat ALPPS and portal vein ligation (PVL) models. Hepatocyte proliferation was assessed based on Ki-67 expression, which was confirmed using immunohistochemistry. The serum concentrations of inflammatory cytokines were measured using enzyme linked immune-solvent assays. The Akt-eNOS pathway was assessed using western blotting. To explore the role of inflammatory cytokines and NO, Kupffer cell inhibitor gadolinium chloride (GdCl), NOS inhibitor N-nitro-arginine methyl ester (L-NAME), and NO enhancer molsidomine were administered intraperitoneally.
The ALPPS group showed significant FLR regeneration (FLR/BW: 1.60% ± 0.08%, < 0.05) compared with that observed in the PVL group (1.33% ± 0.11%) 48 h after surgery. In the ALPPS group, serum interleukin-6 expression was suppressed using GdCl to the same extent as that in the PVL group. However, the FLR/BW ratio and Ki-67 labeling index were significantly higher in the ALPPS group administered GdCl (1.72% ± 0.19%, < 0.05; 22.25% ± 1.30%, < 0.05) than in the PVL group (1.33% ± 0.11% and 12.78% ± 1.55%, respectively). Phospho-Akt Ser and phospho-eNOS Ser levels were enhanced in the ALPPS group compared with those in the PVL group. There was no difference between the ALPPS group treated with L-NAME and the PVL group in the FLR/BW ratio and Ki-67 labeling index. In the PVL group treated with molsidomine, the FLR/BW ratio and Ki-67 labeling index increased to the same level as in the ALPPS group.
Early induction of inflammatory cytokines may not be pivotal for accelerated FLR regeneration after ALPPS, whereas Akt-eNOS pathway activation may contribute to accelerated regeneration of the FLR.
尽管联合肝脏离断和门静脉结扎的分阶段肝切除术(ALPPS)比门静脉栓塞术引起更快的肝再生,但其机制尚不清楚。
评估炎症细胞因子和内皮型一氧化氮合酶(eNOS)激活对 ALPPS 中肝再生的影响。
在大鼠 ALPPS 和门静脉结扎(PVL)模型中评估未来肝体积/体重比(FLR/BW)、肝细胞增殖、炎症细胞因子表达和 Akt-eNOS 途径的激活。基于 Ki-67 表达评估肝细胞增殖,并用免疫组织化学法确认。使用酶联免疫吸附试验测量血清炎症细胞因子浓度。使用 Western blot 评估 Akt-eNOS 途径。为了探讨炎症细胞因子和 NO 的作用,给予 Kupffer 细胞抑制剂钆氯化物(GdCl)、NOS 抑制剂 N-硝基-精氨酸甲酯(L-NAME)和 NO 增强剂莫索尼定腹腔内给药。
ALPPS 组在手术后 48 小时的肝再生(FLR/BW:1.60%±0.08%, <0.05)明显高于 PVL 组(1.33%±0.11%)。在使用 GdCl 抑制 ALPPS 组的白细胞介素-6 表达的程度与 PVL 组相同的情况下。然而,在给予 GdCl 的 ALPPS 组中,FLR/BW 比值和 Ki-67 标记指数显著高于 PVL 组(1.72%±0.19%, <0.05;22.25%±1.30%, <0.05)。与 PVL 组相比,ALPPS 组的磷酸化 Akt Ser 和磷酸化 eNOS Ser 水平增强。在 ALPPS 组中使用 L-NAME 治疗与在 PVL 组中的 FLR/BW 比值和 Ki-67 标记指数无差异。在给予莫索尼定的 PVL 组中,FLR/BW 比值和 Ki-67 标记指数增加到与 ALPPS 组相同的水平。
早期诱导炎症细胞因子可能不是 ALPPS 后加速 FLR 再生的关键,而 Akt-eNOS 途径的激活可能有助于 FLR 的快速再生。